NCT00594334撤回4 期
Effect of Actonel on Periodontal Health of Postmenopausal Women
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Periodontal alveolar bone changes
研究概览
简要总结
Hypothesis: Women who use Actonel (risedronate) for osteopenia will show beneficial periodontal effects.
详细描述
Women who use Actonel for osteopenia will show beneficial attachment loss, alveolar bone height and morphology as compared to those who do not when oral hygiene is corrected for.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 40 Years 至 80 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Osteopenia
- •Postmenopausal
排除标准
- 未提供
研究组 & 干预措施
E, I
Experimental
干预措施: Risedronate (Drug)
结局指标
主要结局
Periodontal alveolar bone changes
时间窗: one year
次要结局
- Periodontal attachment levels(one year)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os WeeklyAlveolar Bone Healing After Dental ExtractionNCT01648686Assistance Publique - Hôpitaux de Paris66
撤回
4 期
Periodontal Profile of Hypogonadic MenHypogonadism, MalePeriodontitisNCT03176537Universidade Federal do Paraná
已完成
3 期
Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm AssessmentBreast CancerNCT00122356Barwon Health303
已完成
不适用
Periodontal Maintenance and the COVID-19 PandemicPeriodontal DiseasesPeriodontal PocketNCT05125835Brock University428
已完成
3 期
Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis WomenPostmenopausal OsteoporosisNCT00165698Eisai Co., Ltd.240